Publication | Closed Access

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

Terminal DifferentiationOncogenic AgentApoptosisImmunologyRetinoic AcidCell DeathArsenic TrioxideMedicineCell BiologyMolecular Medicine